Cargando…
Next-generation direct-acting influenza therapeutics
Influenza viruses are a major threat to human health globally. In addition to further improving vaccine prophylaxis, disease management through antiviral therapeutics constitutes an important component of the current intervention strategy to prevent advance to complicated disease and reduce case-fat...
Autores principales: | Toots, Mart, Plemper, Richard K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7102518/ https://www.ncbi.nlm.nih.gov/pubmed/32088166 http://dx.doi.org/10.1016/j.trsl.2020.01.005 |
Ejemplares similares
-
The paramyxovirus polymerase complex as a target for next-generation anti-paramyxovirus therapeutics
por: Cox, Robert, et al.
Publicado: (2015) -
Systematic Approaches towards the Development of Host-Directed Antiviral Therapeutics
por: Prussia, Andrew, et al.
Publicado: (2011) -
Orally efficacious lead of the AVG inhibitor series targeting a dynamic interface in the respiratory syncytial virus polymerase
por: Sourimant, Julien, et al.
Publicado: (2022) -
The Cell Cycle Timing of Human Papillomavirus DNA Replication
por: Reinson, Tormi, et al.
Publicado: (2015) -
Review of Clinically Relevant Drug Interactions with Next Generation Hepatitis C Direct-acting Antiviral Agents
por: Hong, Jenny, et al.
Publicado: (2020)